Risk factors for Clostridium difficile infection in a hepatology ward

Infection Control and Hospital Epidemiology

Volumn 28, Issue 2, 2007, Pages 202-204

  Vanjak, Dominique ^a   Girault, Guillaume ^a   Branger, Catherine ^a   Rufat, Pierre ^a   Valla, Dominique Charles ^a   Fantin, Bruno ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CORTICOSTEROID; QUINOLONE DERIVATIVE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BACTERIAL INFECTION; BACTERIAL STRAIN; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; FEMALE; HOSPITAL; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; GASTROENTEROLOGY; HEPATITIS, AUTOIMMUNE; HOSPITAL UNITS; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 33847739844     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/511790     Document Type: Article

References (15)

1. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320:204-210.
2. Blot E, Escande MC, Besson D, et al. Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect 2003; 53:187-192.
3. Kyne L, Sougioultzis S, McFarland LV, et al. Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 2002; 23:653-664.
4. Barbut F, Mario M, Meyohas MC, et al. Investigation of a nosocomial outbreak of Clostridium difficile-associated diarrhoea among AIDS patients by random amplified polymorphic DNA (RAPD) assay. J Hosp Infect 1994; 26:181-189.
5. Johnson S, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998; 26:1027-1034.
6. Clabots CR, Johnson S, Peterson LR, Mulligan ME, Silva J. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis 1992; 166:561-567.
7. McFarland LV, Surawicz CM, Stamm WE. Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1990; 162:678-684.
8. Brown E, Talbot GH, Axelrod P, et al. Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 1990; 11:283-290.
9. Lai KK, Melvin ZS, Menard MJ, Kotilainen HR, Baker S. Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control. Infect Control Hosp Epidemiol 1997; 18:628-632.
10. Kato N, Ou CY, Kato H, et al. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol 1991; 29:33-37.
11. Lemann F, Chambon C, Barbut F, et al. Arbitrary primed PCR rules out Clostridium difficile cross-infection among patients in a haematology unit. J Hosp Infect 1997; 35:107-115.
12. Hutin Y, Molina JM, Casin I, et al. Risk factors for Clostridium difficile-associated diarrhoea in HIV-infected patients. AIDS 1993; 7:1441-1447.
13. Gorschlüter M, Glasmacher A, Hahn C, et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001; 33:786-791.
14. Kyne L, Warny M, Qamar A, et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342:390-397.
15. Alvarez F, Berg PA, Bianchi L, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-938.